Industrial Rehabilitation-Mattingly MEDIBALJOURNAL industrial estate is a long way from the hospital. Rehabilitation is not always a continuous process, as it should be, and in graduating from hospital to an I.R.U. the patient passes from the care of one team to another. This problem was recognized by the Piercy Committee in 1956, for they recommended that two or three experimental comprehensive rehabilitation centres should be set up. Such a comprehensive centre would be associated with, and located as closely as possible to, a general hospital, and would provide within its boundaries a variety of services, including physiotherapy department, gymnasium, occupational therapy department, and industrial workshops provided by the Ministry of Labour. Specialist services would be readily available and staff would be shared with the hospital.
The Ad Hoc Committee on Rehabilitation set up by the Sheffield Regional Hospital Board (1962) The use of oral contraceptives has increased very much since the first compound was marketed approximately 10 years ago. An inquiry to leading companies in this country and in the United States engaged in the trade produced estimates varying from 5 million to 20 million women all over the world taking these compounds daily. There is reason to believe that the number of users in Britain is not far short of half a million, and in view of the intehsive advertising campaign conducted in Australia in recent years it would be surprising if they were far behind Britain in this respect. These observations need to be made for two reasons ; first, to demonstrate how widespread their use is, and, secondly, to substantiate the claim that they represent a very considerable financial investment, and the commercial interests backing these drugs have at their disposal a formidable machine of medical persuasion. Any attempt to suggest a choice between trade preparations on the basis of their structure can have commercial results far larger than the available scientific facts would justify. It is not intended, therefore, that any preferences should be implied in classification, but merely to list and subdivide the compounds in common use in this country and to indicate in which respect their composition may be expected to influence their action.
The first fact which strikes one about the composition of all 11 oral contraceptives on the British market to-day (Table I) is that all are dispensed, with an added oestrogen. It is a matter of common agreement that oestrogens will prevent ovulation by suppressing pituitary gonadotrophin secretion, and one of the likeliest theories of how oral contraceptives act is that there is a synergism between the oestrogen and the gestagen, the former suppressing follicle-stimulating hormone (F.S.H.) and the latter luteinizing hormone (L.H.) secretion. This fits with the fact that women on oral contraceptives are, endocrinologically speaking, in a state of medical castration. They produce no endogenous ovarian hormones and give no evidence of the growth of Graafian follicles or corpora lutea. To impose a 28-day cycle on such women is evidence of our adherence to social and lunar convention, not a physiological necessity. In cases where ovulation is not suppressed it is likely that a contraceptive action is exerted at another level-for example, by preventing nidation of the fertilized ovum or by alteration of the cervical mucus. In fact, none of the compounds in use as contraceptives are related to progesterone. Their parent compounds, in the structural sense, are either 19-nortestosterone or, rarely, 17a-hydroxyprogesterone, This is obvious when one looks at the structure of the compound having much the largest share of the British market, norethynodrel. This is shown in Fig. 2 The next most common compound, norethisterone, is also a l9-nortestosterone derivative. Its structure is shown in Fig. 3 , and it in fact differs from norethynodrel only in the position of one double bond. Some of the in Table II. remaining nortestosterone compounds are noted 
